High-Density Lipoproteins for Therapeutic Delivery Systems.

about

Overcoming T. gondii infection and intracellular protein nanocapsules as biomaterials for ultrasonically controlled drug release.Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

P2860

Q38641476-8F97AE58-2866-489D-9930-6FA1F2F4B517 Q38822339-E3AF1273-2016-4232-B634-E1560BDA66FA

P2860

High-Density Lipoproteins for Therapeutic Delivery Systems.

Item

http://www.wikidata.org/entity/Q36781321

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

High-Density Lipoproteins for Therapeutic Delivery Systems.

@en

type

Item

label

High-Density Lipoproteins for Therapeutic Delivery Systems.

@en

prefLabel

High-Density Lipoproteins for Therapeutic Delivery Systems.

@en

P1476

High-Density Lipoproteins for Therapeutic Delivery Systems.

@en

P2093

C Shad Thaxton

http://www.w3.org/2001/XMLSchema#string

Linda Foit

http://www.w3.org/2001/XMLSchema#string

R Kannan Mutharasan

http://www.w3.org/2001/XMLSchema#string

P2860

Scavenger receptor SR-BI in macrophage lipid metabolism

ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

Molecular mechanisms of cellular cholesterol efflux

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platform

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

Nanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung.

P304

188-197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C5TB01332A

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27069624

http://www.w3.org/2001/XMLSchema#string

P932

4825811

http://www.w3.org/2001/XMLSchema#string

High-Density Lipoproteins for Therapeutic Delivery Systems.

about

P2860

P2860

High-Density Lipoproteins for Therapeutic Delivery Systems.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932